“Nobody really knows,” Aaron Smith, executive director of the National Cannabis Industry Association, told the Denver Post’s Cannabist. “It would take an act of Congress, which is a monumental task, getting Congress to act on anything.”
A bill being introduced Monday in the U.S. House of Representatives could be Cox’s ticket home. The three-page bill would amend the Controlled Substances Act — the federal law that criminalizes marijuana — to exempt plants with an extremely low percentage of THC, the chemical that makes users high.
Chronic pain sufferers across America now have access to powerful cannabis-based therapies for their pain. CBD clinical trials across the country are now accepting participants and many pay for the cost of treatment.